Tag archive for ‘Arthritis’

Cipher Pharmaceuticals acquires Canadian rights from Israeli Can-Fite for psoriasis, rheumatoid arthritis treatment

  Cipher Pharmaceuticals Inc. (NASDAQ: CPHR; TSX:CPH) has licensed the Canadian distribution rights to CF101, a novel chemical entity being developed by Israeli Can-Fite Biopharma (NYSE MKT: CANF) (TASE: More...

Jewish Business News On Wednesday, March 18th, 2015

Can-Fite Developed Test to Predict Patients’ Response to Drugs

Israel’s Can-Fite BioPharma Ltd., a biotechnology company which develops proprietary small molecule drugs for treating cancer and inflammatory diseases, has completed the development of a commercial predictive More...

Gil Tanenbaum On Tuesday, December 30th, 2014

Israel’s Can-Fite BioPharma Moves Forward with Rheumatoid Arthritis Drug

Israel’s Can-Fite BioPharma Ltd., a biotechnology company which develops proprietary small molecule drugs for treating cancer and inflammatory diseases, has completed the Design of the Rheumatoid Arthritis More...

Can-Fite Reports Positive Rheumatoid Arthritis Treatment Results

– The 12-week Phase IIb study involving 79 patients with active rheumatoid arthritis met all its primary efficacy endpoints. – Can-Fite BioPharma Ltd. (TASE:CFBI; Bulletin Board:CANFY)  reports More...

Wordpress site Developed by Fixing WordPress Problems